Logo print RMMS Rakoczy Molino Mazzochi Siwik LLP
  • About
  • Services
  • Profiles
  • News
  • Contact
  • X
  • News

News

RMMS Partner William Rakoczy Recognized by Chambers & Partners

07/28/2017

RMMS Scores Win in Europe Relating to Shire’s Factor VIII ADVATE Franchise

05/16/2017

RMMS Named “U.S. Firm to Watch” by Managing Intellectual Property Magazine

03/23/2017

Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution)

03/17/2017

RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL)

01/30/2017

RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution

08/22/2016

RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases

04/27/2016

Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets)

02/01/2016

RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®)

11/16/2015

RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year

10/20/2015
Newer 1 2 3 4 5 6 Older

Services

  • Litigation
    • Small Molecules and Biologics
    • Regulatory Litigation
    • Representative Matters
    • Litigation Highlights
  • Patent Counseling
  • Regulatory Counseling
    • About
    • Services
    • Profiles
    • News
    • Contact
    • Disclaimers
    • Copyright © 2021 Rakoczy Molino Mazzochi Siwik LLP